Updated July 27, 2026
If you live in North Carolina and are researching compounded GLP-1 medications, this page is meant to save you some digging. It explains how access works in the state, what North Carolina’s medical and pharmacy boards actually say about telehealth prescribing and compounded medications, what compounded semaglutide and tirzepatide cost, and how several providers serving the state compare on published cash prices. Everything here is drawn from public sources, with links, so you can check our work.
One disclosure up front: this site is operated by Gentle Health, a telehealth provider offering compounded GLP-1 treatment for weight management. Gentle Health appears in the comparison table below on the same terms as every other provider listed.
How compounded GLP-1 access works in North Carolina
North Carolina does not require you to visit a clinic in person to be evaluated for a GLP-1 prescription. The state’s medical board treats telehealth as ordinary medical practice, held to the same standard of care as an office visit, which means a physician can evaluate you by video or through a structured online intake, decide whether treatment is appropriate, and prescribe if it is.
Here is what that looks like in practice for a Gentle Health patient in North Carolina:
- Complete a medical intake. You answer questions about your health history, current medications, and goals. This is the information a physician needs to decide whether a GLP-1 is appropriate for you.
- Physician review. Your intake is reviewed by James Simmons, MD, who is licensed to practice in North Carolina through the Interstate Medical Licensure Compact (license 2026-04234, state board record). North Carolina joined the Compact effective January 1, 2026, under Session Law 2025-37, which created an expedited licensure pathway for qualified physicians licensed in other Compact states. Dr. Simmons evaluates every North Carolina patient individually; not everyone who applies is approved.
- Prescription and fulfillment. If Dr. Simmons determines treatment is appropriate, the prescription is sent to a licensed compounding pharmacy, and the medication ships to your home anywhere in North Carolina, from Murphy to Manteo.
- Ongoing care. Dosing is adjusted over time based on how you respond, and you can reach Dr. Simmons with questions between check-ins.
The practical upshot: a patient in a small town in the Sandhills has the same access as a patient in Charlotte. No referrals, no waiting rooms, no drive.
North Carolina rules worth knowing
Two state boards shape how compounded GLP-1s reach patients in North Carolina: the North Carolina Medical Board, which governs prescribers, and the North Carolina Board of Pharmacy, which governs the pharmacies that compound and dispense.
Telehealth prescribing. The Medical Board’s Position Statement 5.1.4 on telemedicine is the key document. A few points from it worth knowing:
- The Board “deems the practice of medicine to occur in the state where the patient is located.” If you are in North Carolina, your prescriber needs a North Carolina license, wherever that prescriber happens to sit.
- Telehealth is held to the same standard of care as in-person medicine. There is no separate, looser standard for online visits.
- Prescriptions issued during a telehealth encounter “carry the same professional accountability as prescriptions delivered during an encounter in person.” Where the physician gathers the information needed for an accurate diagnosis, documents the clinical reasoning, and obtains informed consent, the Board permits prescribing through telehealth.
- If a telehealth visit turns out to be insufficient for the situation, the provider should be able to refer the patient to in-person care reasonably close to home.
GLP-1 medications are not controlled substances, so the additional federal and state restrictions that apply to prescribing controlled substances by telemedicine do not apply here.
On licensure, North Carolina’s entry into the Interstate Medical Licensure Compact matters for access. The Compact does not weaken any requirement; a physician licensed through it holds a full, unrestricted North Carolina license issued by the North Carolina Medical Board and answers to that board like any other licensee. What the Compact changes is speed: qualified physicians can be licensed in months rather than the better part of a year, which is part of why more telehealth practices now serve the state.
Compounded GLP-1s and the pharmacy board. The NC Board of Pharmacy’s compounding FAQs address GLP-1s directly, and the Board is candid about where federal law stands. The short version:
- Federal law, specifically Section 503A of the Food, Drug and Cosmetic Act, generally prohibits pharmacies from compounding “drug products that are essentially copies of a commercially available drug product.”
- During the national shortages of semaglutide and tirzepatide products, those drugs were not considered “commercially available,” which opened the door to widespread compounding. The FDA has since declared both shortages resolved: tirzepatide in late 2024 and semaglutide in a February 21, 2025 statement. FDA’s enforcement grace periods for compounders ended April 22, 2025 (for 503A pharmacies) and May 22, 2025 (for 503B outsourcing facilities).
- The NC Board of Pharmacy’s FAQ notes that a federal court denied the compounding industry’s request to block FDA’s shortage determinations in March 2025, and states plainly that compounding copies of the approved tirzepatide products “is no longer allowed.”
What this means for patients: compounded GLP-1s that remain on the market in 2026 are prescribed as individualized formulations for a specific patient, based on a licensed prescriber’s judgment, rather than as copies of the manufactured products. Compounding for an individual patient under a valid prescription remains legal under 503A when the compounded product is not an essential copy. This is an area of active regulatory attention, and the ground can shift: in April 2026, the FDA proposed removing semaglutide and tirzepatide from the list of bulk substances that 503B outsourcing facilities may use, a change that, if finalized, would further narrow how compounded GLP-1s can be made (Pharmacy Times coverage of the proposal). Any pharmacy dispensing into North Carolina, including out-of-state pharmacies, must be licensed or registered with the NC Board of Pharmacy.
None of this is a reason to avoid asking questions. It is a reason to ask more of them: who is prescribing, what pharmacy is compounding, and whether both are licensed for North Carolina.
Compounded semaglutide in North Carolina
Semaglutide is a GLP-1 receptor agonist. It works by mimicking a hormone your body already makes, one that signals fullness, slows how quickly your stomach empties, and helps regulate blood sugar. The practical effect most patients describe is that food quiets down: smaller portions satisfy, and the constant background negotiation with appetite eases.
Compounded semaglutide is prepared by a licensed compounding pharmacy for an individual patient, based on a prescription. It is not FDA-approved, which is a factual difference worth understanding, not a footnote: compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before dispensing. Oversight comes instead from state boards of pharmacy and from the prescribing physician’s judgment about the individual patient. That is exactly why the questions above, about licensure and sourcing, matter.
Gentle Health offers compounded semaglutide to North Carolina patients in two forms, at flat cash prices:
- Oral semaglutide: $112 per month. Taken daily, no needles involved.
- Injectable semaglutide: $135 per month. A once-weekly subcutaneous injection with a small needle.
Both prices are cash-pay and flat across dose levels, so the price does not climb as your dose is adjusted. Treatment is subject to medical evaluation by Dr. Simmons, and continuing care is included rather than billed separately.
Compounded tirzepatide in North Carolina
Tirzepatide works on two hormone receptors rather than one: GLP-1 and GIP. Like semaglutide, it is prescribed for weight management alongside changes to eating and activity; the dual mechanism is the main pharmacological distinction between the two medications. Which one is appropriate for a given patient, if either, is a clinical decision, not a menu choice, and it depends on health history, other medications, and how a patient responds over time.
Compounded tirzepatide, like compounded semaglutide, is prepared for an individual patient by a licensed compounding pharmacy and is not FDA-approved.
Gentle Health offers compounded injectable tirzepatide to North Carolina patients at $169 per month, cash-pay, flat across dose levels, once weekly. As with semaglutide, the evaluation, prescription decision, and ongoing dose adjustments are handled by James Simmons, MD.
Provider options in North Carolina: comparison table
Methodology: rows are ordered alphabetically; prices were taken only from each provider’s public web pages on 2026-07-27, and where a provider does not publish a price we say “See site” rather than guessing. Gentle Health operates this site and is listed on the same terms as everyone else. We do not rank providers.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves North Carolina | Insurance | Source |
|---|---|---|---|---|---|---|
| Eden | Telehealth; medication price plus separate membership ($39 first month, then $99/mo) | $99 + membership | $199 + membership | See site | Not required; HSA/FSA eligible | eden.health (verified 2026-07-30) |
| Gentle Health (operates this site) | Telehealth; care by James Simmons, MD; flat pricing, no separate membership fee | $112 oral / $135 injectable | $169 | Yes | No insurance; cash-pay only | gentlehealth.com (verified 2026-07-27) |
| Medi-Weightloss | In-person clinics (Raleigh and other NC locations) with program fees | See site | See site | Yes (NC clinic locations) | See site | mediweightloss.com (verified 2026-07-30) |
| Mochi Health | Telehealth; medication price plus $79/mo membership | $99 + membership | $199 + membership | Yes (serves all US states per its FAQ) | See site | joinmochi.com (verified 2026-07-30) |
| Noom Med | Telehealth; low-dose program bundling care and medication, billed $537 per 12 weeks after intro | From $179 (low-dose program) | See site | See site (Noom’s page notes it is not available in all 50 states) | Not required; FSA/HSA eligible | noom.com (verified 2026-07-30) |
| Remedy Meds | Telehealth; subscription plans, month-to-month | See site | See site | See site | Not required; HSA/FSA accepted | remedymeds.com (verified 2026-07-30) |
A few reading notes. Headline medication prices and total monthly cost are not the same thing: where a provider charges a separate membership fee, your real monthly outlay is the sum of the two lines. Intro prices are also common in this market, so it is worth checking what month four costs, not just month one. And every provider on this list requires a medical evaluation; a price is only relevant if a licensed prescriber determines treatment is appropriate for you.
Frequently asked questions: compounded GLP-1 in North Carolina
Is compounded semaglutide legal in North Carolina? Compounding for an individual patient under a valid prescription is legal under federal law (Section 503A) and North Carolina law when the pharmacy is licensed and the compounded product is not an essential copy of a commercially available drug. The NC Board of Pharmacy notes that since FDA declared the shortages resolved in 2025, compounding copies of the approved products is no longer permitted, so what remains available are individualized formulations prescribed for specific patients. It is a genuinely evolving area, which is why the prescriber’s and pharmacy’s licensure are worth confirming.
Do I need an in-person doctor visit to get a GLP-1 prescription in North Carolina? No. The NC Medical Board’s telemedicine position statement allows physicians to evaluate and prescribe through telehealth, provided the physician gathers the information needed for an accurate diagnosis and holds the encounter to the same standard of care as an office visit. GLP-1s are not controlled substances, so no special in-person requirement applies.
Who prescribes for Gentle Health patients in North Carolina? James Simmons, MD, who is licensed to practice medicine in North Carolina through the Interstate Medical Licensure Compact. A Compact license is a full North Carolina license issued by the North Carolina Medical Board. Every prescription decision at Gentle Health is made by Dr. Simmons based on an individual medical evaluation.
Does insurance cover compounded GLP-1s in North Carolina? Generally, no. Insurance plans, including North Carolina’s larger commercial plans, typically do not cover compounded medications. Most providers in this market, Gentle Health included, are cash-pay. Some accept HSA or FSA funds; check the individual provider’s site.
How does the medication get to me? After a prescription is issued, a licensed compounding pharmacy prepares your medication and ships it to your address in North Carolina. Pharmacies shipping into the state must be licensed or registered with the NC Board of Pharmacy, including out-of-state pharmacies. Shipments are packaged for temperature control where the formulation requires it.
Can I get compounded GLP-1 treatment anywhere in North Carolina, or only in the big cities? Anywhere in the state. Because the model is telehealth plus home delivery, a patient in Boone, Elizabeth City, or Lumberton has the same access as a patient in Raleigh or Charlotte. That is arguably where telehealth matters most: large stretches of eastern and western North Carolina have limited local access to obesity medicine.
What should I check before choosing a provider in North Carolina? Four things: that a licensed North Carolina prescriber, not a questionnaire alone, makes the prescribing decision; that the pharmacy is licensed with the NC Board of Pharmacy; what the total monthly cost is once membership fees are included; and what ongoing care looks like after the first shipment. Any provider should be able to answer all four plainly.
Reviewed by James Simmons, MD Last updated: August 11, 2026
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.